Abstract
AbstractIn this article, we reported a new library of arylthiadiazole analogs of imidazopyridines (9 a–j) designed based on the structures of Nocodazole and Cefozopran. After characterization by spectroscopic data, the synthesized analogs were assessed for anticancer potential using MTT assay against PC3, A549, MCF‐7 and DU‐145 human cancer cell lines. Etoposide, an anticancer medication candidate, was employed as a positive control. The anticancer activity of the synthesized analogues was expressed in IC50 ranging from 0.01±0.008 μM to 19.3±7.65 μM and compared with positive control. Five compounds 9 d, 9 e, 9 g, 9 h and 9 j possessed more potent anticancer properties.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
